Patient

P2B-049

completed Phase II

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · The Crown Princess Mary Cancer Centre Westmead (Sydney, Australia) (Dr. Kowalski)

consented 2012-11-01

The Crown Princess Mary Cancer Centre Westmead (Sydney, Australia)

Adverse events

Serious AEs

Open data queries

Luna dropout signal

—

not on Luna

Adverse events 3

mild assessed 2012-12-15

Grade 1 oedema peripheral with onset in cycle 2 (2012-12-15); assessed as not related to study drug (not related); resolved 2013-01-21.

severe assessed 2012-11-21

Grade 3 neutropenia with onset in cycle 1 (2012-11-21); assessed as related to study drug (probable); resolved 2012-11-27.

mild assessed 2012-11-18

Grade 1 stomatitis with onset in cycle 1 (2012-11-18); assessed as related to study drug (probable); resolved 2012-11-26.

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users